David A Cory - Net Worth and Insider Trading
David A Cory Net Worth
The estimated net worth of David A Cory is at least $6,512 dollars as of 2024-06-09. David A Cory is the President and CEO of Eiger BioPharmaceuticals Inc and owns about 2,960 shares of Eiger BioPharmaceuticals Inc (EIGRQ) stock worth over $6,512. Details can be seen in David A Cory's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that David A Cory has not made any transactions after 2019-02-04 and currently still holds the listed stock(s).
Transaction Summary of David A Cory
David A Cory Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David A Cory owns 1 companies in total, including Eiger BioPharmaceuticals Inc (EIGRQ) .
Click here to see the complete history of David A Cory’s form 4 insider trades.
Insider Ownership Summary of David A Cory
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| EIGRQ | Eiger BioPharmaceuticals Inc | 2022-03-11 | director & President and CEO |
David A Cory Latest Holdings Summary
David A Cory currently owns a total of 1 stock. David A Cory owns 2,960 shares of Eiger BioPharmaceuticals Inc (EIGRQ) as of February 4, 2019, with a value of $6,512.
Latest Holdings of David A Cory
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| EIGRQ | Eiger BioPharmaceuticals Inc | 2019-02-04 | 2,960 | 2.20 | 6,512 |
Holding Weightings of David A Cory
David A Cory Form 4 Trading Tracker
According to the SEC Form 4 filings, David A Cory has made a total of 0 transactions in Eiger BioPharmaceuticals Inc (EIGRQ) over the past 5 years. The most-recent trade in Eiger BioPharmaceuticals Inc is the acquisition of 8 shares on February 4, 2019, which cost David A Cory around $3,208.
Insider Trading History of David A Cory
- 1
David A Cory Trading Performance
GuruFocus tracks the stock performance after each of David A Cory's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by David A Cory is -22.22%. GuruFocus also compares David A Cory's trading performance to market benchmark return within the same time period. The performance of stocks bought by David A Cory within 3 months outperforms 0 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how David A Cory's insider trading performs compared to the benchmark.
Performance of David A Cory
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -3.81 | | | | | |
| Relative Return to S&P 500(%) | -4.74 | | | | | |
David A Cory Ownership Network
David A Cory Owned Company Details
What does Eiger BioPharmaceuticals Inc do?
Who are the key executives at Eiger BioPharmaceuticals Inc?
David A Cory is the director & President and CEO of Eiger BioPharmaceuticals Inc. Other key executives at Eiger BioPharmaceuticals Inc include 10 percent owner Richard A Kayne , 10 percent owner Leen Kawas , and Chief Business Officer Ingrid Choong .
Eiger BioPharmaceuticals Inc (EIGRQ) Insider Trades Summary
Over the past 18 months, David A Cory made no insider transaction in Eiger BioPharmaceuticals Inc (EIGRQ). Other recent insider transactions involving Eiger BioPharmaceuticals Inc (EIGRQ) include a net purchase of 27,500 shares made by Thomas John Dietz , a net purchase of 278,239 shares made by Richard A Kayne , and a net purchase of 100,000 shares made by Jeffrey S Glenn .
In summary, during the past 3 months, insiders sold 0 shares of Eiger BioPharmaceuticals Inc (EIGRQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 896 shares of Eiger BioPharmaceuticals Inc (EIGRQ) were sold and 15,086 shares were bought by its insiders, resulting in a net purchase of 14,189 shares.
Eiger BioPharmaceuticals Inc (EIGRQ)'s detailed insider trading history can be found in Insider Trading Tracker table.
Eiger BioPharmaceuticals Inc Insider Transactions
David A Cory Mailing Address
Above is the net worth, insider trading, and ownership report for David A Cory. You might contact David A Cory via mailing address: 350 Cambridge Avenue, Suite 350, Palo Alto Ca 94306.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
